Crestchem Share Price

Crestchem Limited, with its corporate operations in Ahmedabad, functions as a nutraceutical ingredients and specialty chemicals manufacturing company in India. The company was incorporated in 1991 and was founded on April 26, 1991 as a body corporate with its securities listed on premier stock exchanges in India. Crestchem is engaged in the business of manufacturing, marketing and exporting products derived from the newly developed field of nutraceutical ingredients, emerging from the conventional chemical, food and pharmaceutical fields. The company offers medium chain triglyceride oil fat powders, medium chain triglyceride oils, spray dried lactose free skimmed milk powders, pediatric and adult nutritional products, and spray dried water-soluble oil and fat powders.

Crestchem share price on BSE signifies how market participants respond to the company‘s operational performance and the overall developments in the nutraceutical ingredients and specialty chemicals sector. The company’s financial health depends on production volumes of nutrition-chemical products, raw material costs including vegetable oils and milk derivatives, capacity utilization rates, export demand, and the performance of its nutritional ingredients and specialty chemicals segments. Crestchem stock price is influenced by various factors such as earnings announcements, regulatory changes in the food and pharmaceutical industry, global vegetable oil price trends, and competition from other nutraceutical ingredient manufacturers. In the longer run, strategies such as launching new products like Capric/Caprylic Triglycerides in oil and powder forms, expanding into new start-up businesses, and collaborating with CSIR for research projects affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company‘s stock price movements.

Crestchem live share price provides real-time information about the last price traded, bid and ask prices, and volume traded on the BSE exchange. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and specialty chemicals sector news. Constant monitoring of the Crestchem live price helps in observing short term price volatility and shows how the stock moves relative to the broader specialty chemicals index. Furthermore, monitoring Crestchem share price movements helps investors understand real-time market sentiment, price fluctuations, and trading behaviour.

Crestchem stock price movements allow market participants to evaluate short-term performance and respond to news, quarterly results, or sector trends that may influence the company‘s valuation and overall investment outlook. The company’s core philosophy is to follow fair business practices, ensuring the satisfaction of all stakeholders including customers, shareholders, and employees. Crestchem continues to focus on nutraceutical ingredients, medium chain triglycerides, and lactose free products as its core business segments, adopting business models that generate required returns while maintaining product quality and regulatory compliance.

Crestchem Limited Company Fundamentals

a. Company Background

Crestchem Limited was incorporated in 1991 on April 26, with its registered office in Ahmedabad, Gujarat. The company operates primarily in the nutraceutical ingredients segment, supplying products derived from the emerging field of nutraceutical ingredients that bridge conventional chemical, food and pharmaceutical fields. Its manufacturing operations are based in India, with corporate functions managed from its administrative offices in Ahmedabad. The company has commercial production history dating back to 1993. Over time, the company has expanded its product portfolio to include caprylic/capric triglycerides in oil and powder forms, lactose free products, and spray dried water-soluble oil and fat powders. The company developed two new products in 2016 namely Capric/Caprylic Triglycerides and Lactose Free products. Financial performance is assessed through standard metrics such as revenue growth, operating margins, and production efficiency. Market valuation indicators such as the P/E ratio are used by analysts for comparative assessment within the specialty chemicals sector. Overall fundamentals are influenced by raw material availability for vegetable oils and milk derivatives, demand cycles in nutritional products and pharmaceuticals, and input cost fluctuations.

b. Company Product Lines

• Medium Chain Triglyceride Oil Fat Powders

o Used primarily by food and nutritional product manufacturers for formulating infant formulas, clinical nutrition products, and dietary supplements.

• Medium Chain Triglyceride Oils

o Supplies pharmaceutical and nutritional companies for specialized dietary applications and therapeutic nutritional products.

• Spray Dried Lactose Free Skimmed Milk Powders

o Serves individuals with lactose intolerance and manufacturers of specialized nutritional products requiring lactose-free formulations.

• Pediatric and Adult Nutritional Products

o Provides complete nutritional solutions for both children requiring specialized nutrition and adults needing dietary supplementation.

• Spray DriedWater-SolubleOil and Fat Powders

o Includes high olic sunflower oil, palm oil, coconut oil, dairy cream, and aromatic oil powders on dairy base materials.

• Caprylic/Capric Triglycerides

o Offered in both oil and powder forms, utilized in various industrial fields including pharmaceuticals and cosmetics.

The product portfolio is structured to serve both domestic nutritional industry demand and select export markets.

c. Company Revenue Model

• Manufacturing Sales

o Revenue generated through manufacturing and sale of nutraceutical ingredients, medium chain triglycerides, and lactose free products to food, pharmaceutical and nutritional companies.

• Export Sales

o Contribution from international customers in global markets for nutraceutical ingredients and specialty chemical products.

• Domestic Institutional Sales

o Supply agreements with large-scale nutritional product manufacturers and pharmaceutical companies in India.

Revenue performance is primarily influenced by demand for nutritional ingredients, raw material costs including vegetable oils and milk derivatives, and selling price realizations in domestic and export markets.

d. Geographic Presence

• Registered Office

o Ahmedabad, Gujarat, India.

• Corporate Headquarters

o Ahmedabad, Gujarat, India.

• Manufacturing Operations

o Production activities based in India.

• Distribution Network

o Domestic supply across India through direct sales and industrial channels.

• Export Markets

o Products supplied to select international markets depending on demand conditions.

e. Key Milestones

• 1991: Incorporation of Crestchem Limited on April 26 in Ahmedabad, Gujarat.
• 1993: Commercial production commenced.
• 2016: Developed two new products namely Capric/Caprylic Triglycerides and Lactose Free products.
• 2024: Board of Directors recommended5%maiden dividend following improved operations.
• Recent years: Collaborating with CSIR for a project with a pilot plant expected.

f. Industry Perspective

The specialty chemicals and nutraceutical ingredients industry is manufacturing-intensive and closely linked to demand from food processing, nutritional products, pharmaceutical and cosmetic sectors. Demand trends are influenced by health awareness, changing consumer preferences, growth in dietary supplements, and increasing demand for specialized nutritional products. The industry is also affected by fluctuations in raw material prices such as vegetable oils and milk derivatives, along with energy and logistics costs. Regulatory compliance for food safety and quality standards are increasingly shaping production practices. Companies in the sector must manage cyclical demand patterns and cost volatility while maintaining product quality and consistency. These factors collectively influence financial performance and investor perception of firms like Crestchem.

Crestchem Limited Stock Market Presence: Listings & Index Representation

Crestchem Limited is listed on the Bombay Stock Exchange (BSE) under the scrip code 526269. Crestchem share price is actively traded on the BSE platform under the security ID CRSTCHM. The company is not listed on the National Stock Exchange (NSE) for regular trading. Crestchem stock price is available for trading exclusively on the BSE exchange with a face value of Rs 10 per share. The company‘s market presence is within the small-cap segment of the market, specifically under the specialty chemicals industry. Due to its size and sector focus, Crestchem share price is generally tracked by investors interested in the nutraceutical ingredients and specialty chemicals sector.

Crestchem stock price finds representation in broad-based stock market indices that track the chemicals and specialty chemicals sector. The company is included as a constituent of the BSE SmallCap index within the chemicals category. Crestchem price also forms part of sector-specific indices that monitor specialty chemicals and nutraceutical companies. Crestchem stock price movement relative to these indices provides context for understanding the company‘s market standing. This representation helps investors track the stock relative to other specialty chemical and nutraceutical ingredients companies operating in the Indian market. The company’s inclusion in these indices underscores its presence within the broader specialty chemicals ecosystem.

Crestchem Limited Stock Performance and Share Price History

Crestchem share price today on the BSE reflects its position as a nutraceutical ingredients and specialty chemicals manufacturer serving the food, pharmaceutical and nutritional sectors in India. Its performance is qualitatively driven by factors such as production capacity utilization, management of raw material costs including vegetable oils and milk derivatives, growth in export sales, and the ability to control operational expenses. Investors compare the stock‘s current movement with other specialty chemicals and nutraceutical companies to assess relative strength. Crestchem price movements become visible through real market movements across different time periods.

Crestchem stock price shows patterns during earnings-driven price changes. Broader sector strength has also supported the stock from time to time. Beyond operational and sector influences, corporate actions such as the company’s collaboration with CSIR for research projects and its plans to invest in new start-up businesses can significantly affect Crestchem price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short-term swings, even within a regulatory environment influenced by food safety standards and nutraceutical regulations.

While short-term movements respond to events and announcements, longer-term valuation trends are captured by the stock‘s annual high and low levels, offering context beyond daily or weekly changes. A notable peak in Crestchem price indicates stronger demand for nutritional ingredients and stable input costs, whereas a significant low aligns with market corrections or specialty chemicals sector volatility. These extremes reflect the impact of trade policies, global vegetable oil price trends, and earnings visibility, providing a framework for understanding historical performance of Crestchem stock price.

Crestchem share price behavior mirrors the trading patterns of a small-cap specialty chemicals company within India’s nutraceutical ingredients ecosystem. The company‘s diversified product portfolio spanning medium chain triglycerides, lactose free products, pediatric and adult nutritional products, and spray dried water soluble oil powders has shaped its price history. Over recent periods, Crestchem price has experienced periods of sharp gains followed by phases of consolidation. For instance, the stock reached a 52-week high and a 52-week low at various points, reflecting significant price swings from its peak levels. Crestchem price has shown higher volatility compared to the overall market.

The company’s performance has closely tracked India‘s nutritional products demand and global vegetable oil price cycles. Positive momentum for Crestchem share price appeared during periods of increased demand for specialty nutritional ingredients and growth in the nutraceutical market. However, periods of high raw material costs and competitive pressure from larger specialty chemical manufacturers have led to consolidation in Crestchem price. Profitability has faced challenges due to variable input cost cycles and pricing pressures, highlighting the cyclical nature of the nutraceutical ingredients industry. Crestchem price has reflected these challenges through periods of price adjustment.

Crestchem stock price experienced a notable decline during challenging market conditions. A drop in export demand for nutraceutical ingredients or deterioration in product realizations directly impacts profitability and leads to selling pressure, which pulls Crestchem price lower. Changes in government policy such as adjustments in food safety regulations or modifications in import duties on vegetable oils can also cause the stock to fall. Moreover, increases in operational costs without matching price increases squeeze margins, making Crestchem price less attractive to market participants.

Periods of economic slowdown that affect consumer spending on nutritional supplements and specialty foods raise concerns about ingredient demand, leading to price declines in Crestchem price. Crestchem price is sensitive to raw material price movements. If vegetable oil or milk derivative prices rise significantly, it can cause the stock to fall as investors adjust expectations for future margin compression. Broader market sell-offs in small cap stocks also pull Crestchem price down, regardless of the company‘s individual performance.

Lower production volumes or reduced export orders directly impacts revenue, resulting in a lower valuation for Crestchem share price. The company has faced headwinds from fluctuating raw material costs, increased competitive pressures from larger specialty chemical and nutraceutical players, and the need to maintain quality certifications to retain international clients. Crestchem price has also been affected by the company‘s investment in research and development activities, which add to operational expenses without immediate revenue contribution.

The company maintains a strong focus on its core nutraceutical ingredients business while exploring opportunities to expand through CSIR collaboration for pilot plant development. Crestchem share price has shown that the company’s strategy of offering caprylic/capric triglycerides in both oil and powder forms and developing lactose free products has provided growth opportunities during favourable market cycles. However, the competitive landscape and the presence of larger specialty chemical companies with significant scale advantages continue to influence Crestchem price movements. Crestchem price remains closely watched by market participants for signals about raw material price trends and export order growth.

Crestchem Limited Investor Relevance and Role in Portfolio

Crestchem price is relevant for investors seeking exposure to the specialty chemicals sector with a focus on small-cap nutraceutical ingredients manufacturing companies. The company‘s inclusion in small-cap and specialty chemicals indices underscores its importance in India’s nutraceutical ingredients space. Crestchem position as a manufacturer of medium chain triglycerides, lactose free products, and spray dried water soluble oil powders, together with its commercial production history since 1993 and its collaborative research with CSIR, makes it a consideration for certain portfolio allocations.

Crestchem share price is influenced by the company‘s ownership structure. The company’s equity is held by a mix of promoters and public investors, reflecting its standing in India‘s specialty chemicals sector. Promoters hold a stable stake of 30.04 per cent as of March 2026, reflecting internal control under the leadership of Dipak Narendraprasad Patel as Chairman and Managing Director. Foreign institutional investors hold no shares in the company. Domestic institutional investors hold a very small fraction of 0.13 per cent of the company’s shares. Mutual funds hold no stake in Crestchem. The public holds the remaining stake of 69.83 per cent, including retail investors and other entities. The company‘s management includes named board members including Dipak Narendraprasad Patel as Chairman and Managing Director, Nitinkumar Shantilal Shah as CFO and Company Secretary, and other independent directors. Promoters have pledged none of their holdings, indicating no pledge risk. This investor base, with stable promoter participation and no institutional holdings, underscores the company’s role as a holding in focused portfolios concentrating on small-cap nutraceutical manufacturing.

Beyond fundamentals and ownership, Crestchem stock price is actively monitored in cash market segments on the BSE exchange. Trading volumes and delivery patterns reflect expectations on export demand, raw material price trends, and regulatory policy actions from food safety authorities. The stock is available for trading on the BSE exchange, allowing investors to take positions based on their outlook for the specialty chemicals sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements related to nutraceutical regulations.

Technical indicators provide additional insight into short term momentum shifts in Crestchem share price. While these indicators are primarily used for near term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short term and weekly timeframe, the stock has exhibited price movements that correlate with broader specialty chemicals sector trends. Based on available data, the stock‘s beta of 0.59 indicates lower volatility compared to the broader market, suggesting that Crestchem share price movements may be less pronounced relative to the overall index, with the stock having 10.6% average weekly movement versus 7.3% industry average.

Overall, Crestchem share price demonstrates a moderate volatility profile that makes it less sensitive to broader market movements compared to many small-cap stocks, while still being sensitive to sector specific factors such as raw material cost fluctuations, export demand from nutritional product manufacturers, regulatory changes affecting nutraceuticals, and competition from larger specialty chemical companies. The company’s debt to equity ratio of approximately 0.0 indicates a debt-free balance sheet, providing financial flexibility. Return on equity is measured at strong levels of around 27-29 per cent, and the company‘s book value per share serves as a reference point for valuation assessments by market participants.

Crestchem Limited Sectoral Relevance and Peer Positioning

Crestchem Limited sector relevance stems from its three-decade presence in the specialty chemicals industry, its position as a manufacturer and exporter of nutraceutical ingredients derived from the emerging field of nutritional chemistry, its product portfolio including medium chain triglyceride oil fat powders, medium chain triglyceride oils, spray dried lactose free skimmed milk powders, pediatric and adult nutritional products, and spray dried water soluble oil and fat powders, its development of new products Capric/Caprylic Triglycerides and Lactose Free products in 2016, its caprylic/capric triglycerides offered in both oil and powder forms utilized in various industrial fields, its collaboration with CSIR for a research project with a pilot plant expected, its plans to invest in new start-up businesses for growth, its commercial production history dating back to 1993, and its maiden dividend declared following improved operations, establishing it as a focused small-cap nutraceutical ingredients provider supporting India’s food, pharmaceutical and nutritional ecosystem. Crestchem share price is compared with peers like BASF India, Fine Organic Industries, Alkyl Amines Chemicals, Caprolactam Chemicals, Haryana Leather Chemicals, Roopa Industries, and Yug Decor. These comparisons focus on product portfolio composition, export presence, research and development capabilities, and value-added product diversification rather than short-term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of vegetable oil prices, nutraceutical demand trends, and government food safety policies further highlights Crestchem positioning within India‘s broader specialty chemicals market.

Crestchem market cap history reflects the company’s position as a small-cap player within India’s specialty chemicals sector. Based on available data, the company‘s market capitalization has fluctuated within a range of approximately Rs 36 crores to Rs 44 crores depending on the reporting period. The market cap has moved in line with investor perceptions of the company’s growth potential following various market cycles. From earlier years through more recent periods, the market cap showed an increasing trend as the company expanded its product portfolio and developed new products, followed by periods of contraction. This pattern reflects investor confidence during favourable nutraceutical demand cycles, followed by contraction during challenging periods impacted by rising raw material costs and competitive pressures from larger specialty chemical players. This movement mirrors the pattern in Crestchem share price from its various levels over time.

Crestchem earnings trajectory demonstrates the impact of its operational execution in a competitive specialty chemicals industry. In recent fiscal years, total income showed strong growth supported by the core nutraceutical ingredients business. Based on available data, the company‘s revenue from operations increased from Rs 21.26 crores in FY24 to Rs 25.08 crores in FY25, showing healthy growth, and further to Rs 29.61 crores as of March 2026. Profit after tax increased from Rs 2.15 crores in FY24 to Rs 2.73 crores in FY25, representing strong profit growth. However, quarterly performance has shown certain patterns, with net profit of Rs 0.72 crores in December 2025 quarter compared to Rs 0.61 crores in March 2025 quarter, showing positive movement. The company has faced headwinds from fluctuating vegetable oil and milk derivative costs, increased competitive pressures from larger specialty chemical players, and the need to maintain quality certifications to retain export clients. However, the company has continued to focus on its core nutraceutical ingredients business and expects to benefit from growing demand for specialty nutritional products. These developments illustrate the cyclical nature of the specialty chemicals industry and the company’s position within this sector. Crestchem share price has moved in response to these earnings patterns.

Crestchem EPS provides insight into its operational performance and income generation from nutraceutical ingredients manufacturing and export activities. Based on available data, the company reported a basic EPS in certain recent quarters showing certain patterns compared to previous periods. The trailing twelve month EPS stands at Rs 7.42 per share as per available data. The company’s EPS for the last full fiscal year of FY25 was Rs 9.09, which was higher compared to FY24 EPS of Rs 7.15. The company has a face value per share of Rs 10 and is promoted by the Patel family. More recent quarterly performance suggests that EPS has shown certain movements as the company manages its revenue growth and operational costs in a challenging environment. Crestchem share price has reflected these EPS trends over time.

Crestchem P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from nutraceutical ingredients manufacturing and export activities. Based on available data, the current P/E ratio stands at approximately 16 to 24 times depending on the reporting period, which represents a discount compared to the industry average of approximately 28 to 43 times. The company‘s profit after tax increased from previous fiscal years to more recent periods, reflecting the company’s healthy earnings growth. However, quarterly performance has shown certain patterns, with profit after tax and total income showing changes on a quarter on quarter basis. The company‘s earnings before interest and taxes for recent periods stood at certain levels with corresponding margins. The net profit margin showed certain changes in recent quarters compared to earlier periods. Overall, these changes highlight how market sentiment evolves alongside the company’s operational performance in a cyclical industry. Crestchem price has moved in line with these valuation changes.

Summary

Crestchem operates as a small-cap nutraceutical ingredients and specialty chemicals manufacturer serving food, pharmaceutical and nutritional sectors in India and export markets. Crestchem share price movements reflect the company‘s nutraceutical ingredient production volumes and raw material cost management. Crestchem stock price is influenced by specialty chemicals sector policies, vegetable oil price cycles, and competitive dynamics in the nutraceutical ingredients industry. The company has commercial production history dating back to 1993 and collaborates with CSIR for research projects with a pilot plant expected. Promoters hold a stable stake of 30.04 per cent in the company.